personalized diagnostics

IMMS harnesses for point-of-care diagnostics

At the MEDICA 2016 IMMS is presenting its first approaches for the personalized diagnostics of cancer using a prototype device. It was developed in the three-year research project INSPECT which started in June 2016.

Devices performing rapid, reliable, cost-efficient and automated POC...
Devices performing rapid, reliable, cost-efficient and automated POC diagnostics should look like this in the future. IMMS presents a prototype device with live demonstration to showcase its developments for personalized cancer diagnostics.
Source: IMMS

IMMS focusses on the integration of various sensor principles of different biological and chemical measurands into one integrated electronic device for extensive and precise diagnostics. The work is based on cost-efficient standard semiconductor manufacturing processes (CMOS) which IMMS also uses for these new diagnostic approaches.

IMMS adapts its systems to application-specific needs by means of particular functionalisation of surfaces and the use of biocompatible material. These solutions should pave the way for fast, reliable, cost-efficient and automated in-vitro diagnostics, such as early recognition of cancer.

In the INSPECT research project IMMS is developing systems for the early recognition of breast, cervical, prostate and lung cancers using semiconductor chips as well as immunological and cell-based biotechnological methods. IMMS is working on an interdisciplinary interface between biology and microelectronics for signal processing. In addition, further concepts for microelectronic-based point-of-care diagnostics and for personalized cancer immunotherapies are being investigated. IMMS is currently testing the first prototypes of the miniaturized diagnostic devices. The research partners iba Institut für Bioprozess- und Analysenmesstechnik e.V. Heiligenstadt, Senova Gesellschaft für Biowissenschaft und Technik mbH Weimar, CDA GmbH Suhl and X-FAB Semiconductor Foundries AG Erfurt are contributing to the novel solutions. IMMS is coordinating the consortium.

Funding:
The INSPECT project receives funding from the “Land” of Thüringen and the European Union (European Regional Development Fund (ERDF, German EFRE) under the reference 2015 FE 9159.


Source: IMMS

16.11.2016

Read all latest stories

Related articles

Photo

News • Liquid biopsy for early detection of brain tumours

Glioblastoma: Mathematical modelling could lead to simple blood test

The development of a simple blood test for glioblastomas could mean earlier diagnosis and more effective and personalised treatment options against the most common type of malignant brain cancer.

Photo

News • Dermatology tool

Skin cancer detection: handheld device as painless alternative to biopsy

A new handheld device has been developed to painlessly identify skin cancers using millimeter-wave imaging. This could slash the rate of unnecessary biopsies.

Photo

News • Oncology early detection tool

Blood test for 50+ types of cancer promising for screening

Final results from a study of a blood test that can detect more than 50 types of cancer have shown that it is accurate enough to be rolled out as a multi-cancer screening test among people at higher…

Related products

Canon – Alphenix 4D CT

Multi-Modality Suites

Canon – Alphenix 4D CT

Canon Medical Systems Europe B.V.
Canon - Aquilion Exceed LB

Oncology CT

Canon - Aquilion Exceed LB

Canon Medical Systems Europe B.V.
Canon – Aquilion LB

Oncology CT

Canon – Aquilion LB

Canon Medical Systems Europe B.V.
Canon – Vitrea Advanced Visualization

Reading

Canon – Vitrea Advanced Visualization

Canon Medical Systems Europe B.V.
KABE Labortechnik – Consumables for blood gas analysis

Blood Gases /Electrolytes /Oximetry

KABE Labortechnik – Consumables for blood gas analysis

KABE LABORTECHNIK GmbH
KABE Labortechnik – Consumables for pathology / histology

Histology Equipment

KABE Labortechnik – Consumables for pathology / histology

KABE LABORTECHNIK GmbH
Subscribe to Newsletter